Document Detail

Protecting the people?: risk communication and the chequered history and performance of bureaucracy.
MedLine Citation:
PMID:  23061778     Owner:  NLM     Status:  MEDLINE    
The history and characteristics of bureaucracy1 are examined with a view to understanding the impact of the bureaucratic mindset on medicines' regulation, the pharmaceutical industry and healthcare delivery with a focus on risk communication, pharmacovigilance and patient safety. Controversies and allegations relating to common, negative effects of bureaucratic regulatory and management systems are reviewed and examples of creative and effective practice provided. Strategic directions and specific actions for reform are proposed.2.
Bruce Hugman
Related Documents :
10151118 - The evolving role of pharmacy benefits management firms in a managed care environment.
15651468 - 2003 cdc guidelines offer more choices for managing operatory surfaces.
2640458 - Ways of assessing practice performance.
3515378 - The placebo concept in medicine and psychiatry.
18481668 - Survey of organizational job stress among physical education managers.
17266078 - Barriers in the management of glucocorticoid-induced osteoporosis.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Drug safety     Volume:  35     ISSN:  0114-5916     ISO Abbreviation:  Drug Saf     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-10-15     Completed Date:  2013-02-28     Revised Date:  2014-11-17    
Medline Journal Info:
Nlm Unique ID:  9002928     Medline TA:  Drug Saf     Country:  New Zealand    
Other Details:
Languages:  eng     Pagination:  1005-25     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Drug Industry / legislation & jurisprudence*
Drug-Related Side Effects and Adverse Reactions* / chemically induced*,  psychology
Health Knowledge, Attitudes, Practice
Health Personnel
Legislation, Drug
Physician-Patient Relations
Risk Management

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Challenges of drug risk communications in the Philippines.
Next Document:  Risk Communication and the Pharmaceutical Industry: what is the reality?